There are 2867 resources available
839P - A retrospective study on the long-term survival and incidence of metachronous malignancies in advanced melanoma patients treated with immune checkpoint blockade (ICB)
Presenter: Francois Verschaeve
Session: Poster session 03
1525TiP - TORNADO: A randomized multicenter open-label phase II study evaluating retifanlimab in combination with neoadjuvant chemotherapy in patients with selected retroperitoneal sarcomas
Presenter: Sabrina ALBERT
Session: Poster session 11
1112P - Real-world treatment (tx) patterns and outcomes based on PD-L1 status in tx-naive patients (pts) with METex14 advanced non-small cell lung cancer (aNSCLC)
Presenter: Natasha Leighl
Session: Poster session 15
1526TiP - TOLERANCE: An EORTC STBSG-QLG-ETF 3-arm randomized study on health-related quality of life of elderly patients with advanced soft tissue sarcoma undergoing doxorubicin alone three weekly or doxorubicin weekly or cyclophosphamide plus predniso(lo)ne treatment
Presenter: Winette Van Der Graaf
Session: Poster session 11
1113P - Real-world multicentre cohort of 1L pembrolizumab alone or in combination with platinum-based chemotherapy in NSCLC PD-L1 ≥ 50%
Presenter: Elvire Pons-Tostivint
Session: Poster session 15
841P - Effects of immune checkpoint inhibitor-based combination therapies on the gut microbiota in advanced melanoma patients
Presenter: Jingjing Li
Session: Poster session 03
1527TiP - CONGRATS-combination of nivolumab plus relatlimab in patients with advanced or metastatic soft-tissue sarcoma: A proof-of-concept randomized phase II study
Presenter: Mariella Spalato Ceruso
Session: Poster session 11
1114P - Long-term outcome in Danish real-life patients with advanced non-small cell lung cancer (NSCLC) receiving immune checkpoint inhibitors
Presenter: Birgitte Bjornhart
Session: Poster session 15